Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/53761
Title: Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support among Patients with Septic Shock: The VITAMINS Randomized Clinical Trial
Authors: Tomoko Fujii
Nora Luethi
Paul J. Young
Daniel R. Frei
Glenn M. Eastwood
Craig J. French
Adam M. Deane
Yahya Shehabi
Ludhmila A. Hajjar
Gisele Oliveira
Andrew A. Udy
Neil Orford
Samantha J. Edney
Anna L. Hunt
Harriet L. Judd
Laurent Bitker
Luca Cioccari
Thummaporn Naorungroj
Fumitaka Yanase
Samantha Bates
Forbes McGain
Elizabeth P. Hudson
Wisam Al-Bassam
Dhiraj Bhatia Dwivedi
Chloe Peppin
Phoebe McCracken
Judit Orosz
Michael Bailey
Rinaldo Bellomo
Graduate School of Medicine
Melbourne Medical School
Institut fur Sozial- und Praventivmedizin
Western Health
University of New South Wales (UNSW) Australia
University of Melbourne
Wellington Hospital, New Zealand
Barwon Health
Monash University
Medical Research Institute of New Zealand
Deakin University
Faculty of Medicine, Siriraj Hospital, Mahidol University
UniversitätsSpital Bern
Hopital de la Croix-Rousse
Alfred Hospital
Austin Hospital
Cancer Institute of the State of São Paulo
Keywords: Medicine
Issue Date: 4-Feb-2020
Citation: JAMA - Journal of the American Medical Association. Vol.323, No.5 (2020), 423-431
Abstract: © 2020 American Medical Association. All rights reserved. Importance: It is unclear whether vitamin C, hydrocortisone, and thiamine are more effective than hydrocortisone alone in expediting resolution of septic shock. Objective: To determine whether the combination of vitamin C, hydrocortisone, and thiamine, compared with hydrocortisone alone, improves the duration of time alive and free of vasopressor administration in patients with septic shock. Design, Setting, and Participants: Multicenter, open-label, randomized clinical trial conducted in 10 intensive care units in Australia, New Zealand, and Brazil that recruited 216 patients fulfilling the Sepsis-3 definition of septic shock. The first patient was enrolled on May 8, 2018, and the last on July 9, 2019. The final date of follow-up was October 6, 2019. Interventions: Patients were randomized to the intervention group (n = 109), consisting of intravenous vitamin C (1.5 g every 6 hours), hydrocortisone (50 mg every 6 hours), and thiamine (200 mg every 12 hours), or to the control group (n = 107), consisting of intravenous hydrocortisone (50 mg every 6 hours) alone until shock resolution or up to 10 days. Main Outcomes and Measures: The primary trial outcome was duration of time alive and free of vasopressor administration up to day 7. Ten secondary outcomes were prespecified, including 90-day mortality. Results: Among 216 patients who were randomized, 211 provided consent and completed the primary outcome measurement (mean age, 61.7 years [SD, 15.0]; 133 men [63%]). Time alive and vasopressor free up to day 7 was 122.1 hours (interquartile range [IQR], 76.3-145.4 hours) in the intervention group and 124.6 hours (IQR, 82.1-147.0 hours) in the control group; the median of all paired differences was-0.6 hours (95% CI,-8.3 to 7.2 hours; P =.83). Of 10 prespecified secondary outcomes, 9 showed no statistically significant difference. Ninety-day mortality was 30/105 (28.6%) in the intervention group and 25/102 (24.5%) in the control group (hazard ratio, 1.18; 95% CI, 0.69-2.00). No serious adverse events were reported. Conclusions and Relevance: In patients with septic shock, treatment with intravenous vitamin C, hydrocortisone, and thiamine, compared with intravenous hydrocortisone alone, did not significantly improve the duration of time alive and free of vasopressor administration over 7 days. The finding suggests that treatment with intravenous vitamin C, hydrocortisone, and thiamine does not lead to a more rapid resolution of septic shock compared with intravenous hydrocortisone alone.
URI: http://repository.li.mahidol.ac.th/dspace/handle/123456789/53761
metadata.dc.identifier.url: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85077977882&origin=inward
ISSN: 15383598
00987484
Appears in Collections:Scopus 2020

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.